{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T18:51:05Z","timestamp":1790621465304,"version":"4.1.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Heart Failure"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/j.jchf.2017.07.009","type":"journal-article","created":{"date-parts":[[2017,10,30]],"date-time":"2017-10-30T14:15:20Z","timestamp":1509372920000},"page":"823-832","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":108,"title":["Targeted Metabolomic Profiling of Plasma and Survival in Heart Failure Patients"],"prefix":"10.1016","volume":"5","author":[{"given":"David E.","family":"Lanfear","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph J.","family":"Gibbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruicong","family":"She","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Petucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Culver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.H. Wilson","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yigal M.","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Keoki","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani N.","family":"Sabbah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Gardell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jchf.2017.07.009_bib1","first-page":"e2","article-title":"Heart disease and stroke statistics - 2012 update: a report from the American Heart Association","volume":"125","author":"Roger VL","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2017.07.009_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11897-011-0076-2","article-title":"Pharmacogenetics in chronic heart failure: new developments and current challenges","volume":"9","author":"Talameh","year":"2012","journal-title":"Curr Heart Fail Rep"},{"key":"10.1016\/j.jchf.2017.07.009_bib3","first-page":"1404","article-title":"Predicting\u00a0survival in heart failure: a risk score based on 39 372 patients from 30 studies","volume":"34","author":"Pocock","year":"2013","journal-title":"Eur\u00a0Heart J"},{"key":"10.1016\/j.jchf.2017.07.009_bib4","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1373\/clinchem.2011.165720","article-title":"Emerging biomarkers in heart failure","volume":"58","author":"van Kimmenade","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/j.jchf.2017.07.009_bib5","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/CIRCULATIONAHA.111.060368","article-title":"Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function","volume":"126","author":"Shah","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2017.07.009_bib6","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ahj.2012.02.005","article-title":"Baseline metabolomic profiles predict cardiovascular events in patients at risk for coronary artery disease","volume":"163","author":"Shah","year":"2012","journal-title":"Am Heart J"},{"key":"10.1016\/j.jchf.2017.07.009_bib7","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1016\/j.jacc.2009.02.036","article-title":"Diminished global arginine bioavailability and increased arginine catabolism as metabolic profile of increased cardiovascular risk","volume":"53","author":"Tang","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2017.07.009_bib8","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.redox.2017.04.032","article-title":"Comprehensive metabolomics identified lipid peroxidation as a prominent feature in human plasma of patients with coronary heart diseases","volume":"12","author":"Lu","year":"2017","journal-title":"Redox Biol"},{"key":"10.1016\/j.jchf.2017.07.009_bib9","doi-asserted-by":"crossref","first-page":"e0175591","DOI":"10.1371\/journal.pone.0175591","article-title":"Identification of a plasma metabolomic signature of thrombotic myocardial infarction that is distinct from non-thrombotic myocardial infarction and stable coronary artery disease","volume":"12","author":"DeFilippis","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.jchf.2017.07.009_bib10","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jprot.2017.03.014","article-title":"Systems characterization of differential plasma metabolome perturbations following thrombotic and non-thrombotic myocardial infarction","volume":"160","author":"Trainor","year":"2017","journal-title":"J\u00a0Proteomics"},{"key":"10.1016\/j.jchf.2017.07.009_bib11","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/aje\/kwt002","article-title":"The association of plasma lactate with incident cardiovascular outcomes: the ARIC study","volume":"178","author":"Matsushita Kunihiro","year":"2013","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jchf.2017.07.009_bib12","doi-asserted-by":"crossref","first-page":"e99058","DOI":"10.1371\/journal.pone.0099058","article-title":"Increases\u00a0in myocardial workload induced by rapid\u00a0atrial pacing trigger alterations in global metabolism","volume":"9","author":"Turer Aslan","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jchf.2017.07.009_bib13","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1093\/aje\/kwt004","article-title":"Associations between metabolomic compounds and incident heart failure among African Americans: the ARIC Study","volume":"178","author":"Zheng","year":"2013","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jchf.2017.07.009_bib14","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s11306-007-0063-5","article-title":"Serum metabolomics reveals many novel metabolic markers of heart failure, including pseudouridine and 2-oxoglutarate","volume":"3","author":"Dunn","year":"2007","journal-title":"Metabolomics"},{"key":"10.1016\/j.jchf.2017.07.009_bib15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.cardfail.2013.01.001","article-title":"Diminished global arginine bioavailability as a metabolic defect in chronic systolic heart failure","volume":"19","author":"Tang","year":"2013","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jchf.2017.07.009_bib16","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/CIRCULATIONAHA.115.017355","article-title":"The failing heart relies on ketone bodies as a fuel","volume":"133","author":"Aubert","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2017.07.009_bib17","doi-asserted-by":"crossref","first-page":"e0119265","DOI":"10.1371\/journal.pone.0119265","article-title":"Multimarker\u00a0proteomic profiling for prediction of cardiovascular mortality in patients with chronic heart failure","volume":"10","author":"Lemesle","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jchf.2017.07.009_bib18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jacc.2015.10.079","article-title":"Prognostic\u00a0implications of long-chain acylcarnitines in heart failure and reversibility with mechanical circulatory support","volume":"67","author":"Ahmad","year":"2016","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2017.07.009_bib19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0166-4328(01)00297-2","article-title":"Controlling the false discovery rate in behavior genetics research","volume":"125","author":"Benjamini Y","year":"2001","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.jchf.2017.07.009_bib20","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/bib\/bbr001","article-title":"Using cross-validation to evaluate predictive accuracy of survival risk classifiers based on high-dimensional data","volume":"12","author":"Simon RM","year":"2011","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.jchf.2017.07.009_bib21","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1161\/CIRCHEARTFAILURE.112.000043","article-title":"Risk prediction models for mortality in ambulatory patients with heart failure: a systematic review","volume":"6","author":"Alba","year":"2013","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.jchf.2017.07.009_bib22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3949\/ccjm.81a.13045","article-title":"Heart failure in African Americans: disparities can be overcome","volume":"81","author":"Sharma","year":"2014","journal-title":"Cleveland Clin J Med"},{"key":"10.1016\/j.jchf.2017.07.009_bib23","doi-asserted-by":"crossref","first-page":"831","DOI":"10.3390\/ijms18040831","article-title":"Skeletal muscle nucleo-mitochondrial crosstalk in\u00a0obesity and type 2 diabetes","volume":"18","author":"Devarshi","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jchf.2017.07.009_bib24","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/CIRCULATIONAHA.111.060368","article-title":"Metabolic profiling for identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function","volume":"126","author":"Shah SH","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2017.07.009_bib25","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1161\/CIRCULATIONAHA.108.816116","article-title":"Metabolomic profiling reveals distinct patterns for myocardial substrate utilization in humans with coronary artery disease or left ventricular dysfunction during surgical ischemia-reperfusion","volume":"110","author":"Turer AT","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.jchf.2017.07.009_bib26","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/j.jacc.2015.02.018","article-title":"Metabolic\u00a0disturbances identified in plasma are associated with outcomes in patients with heart failure: diagnostic and prognostic value of metabolomics","volume":"65","author":"Cheng","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2017.07.009_bib27","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.atherosclerosis.2013.10.036","article-title":"Validation of the association between a branched chain amino acid metabolite profile and extremes of coronary artery disease in patients referred for cardiac catheterization","volume":"232","author":"Bhattacharya","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jchf.2017.07.009_bib28","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1016\/j.bbadis.2014.07.018","article-title":"Increased serum 2-oxoglutarate associated with high myocardial energy expenditure and poor prognosis in chronic heart failure patients","volume":"1842","author":"Chen","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jchf.2017.07.009_bib29","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s11306-007-0063-5","article-title":"Serum metabolomics reveals many novel metabolic markers of heart failure, including pseudouridine and 2-oxoglutarate","volume":"3","author":"Dunn","year":"2007","journal-title":"Metabolomics"},{"key":"10.1016\/j.jchf.2017.07.009_bib30","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.jacc.2014.11.048","article-title":"Soluble neprilysin is predictive of cardiovascular death and\u00a0heart failure hospitalization in heart failure patients","volume":"65","author":"Bay\u00e9s-Gen\u00eds","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jchf.2017.07.009_bib31","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1093\/eurheartj\/ehn023","article-title":"Usefulness of clinical and NT-proBNP monitoring\u00a0for prognostic guidance in destabilized heart failure outpatients","volume":"29","author":"Pascual-Figal","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jchf.2017.07.009_bib32","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/cvr\/cvn184","article-title":"Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation","volume":"80","author":"Rosca","year":"2008","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.jchf.2017.07.009_bib33","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s10741-005-7542-4","article-title":"Metabolic therapy for ischemic heart disease: the rationale for inhibition of fatty acid oxidation","volume":"10","author":"Stanley","year":"2005","journal-title":"Heart Fail Rev"},{"key":"10.1016\/j.jchf.2017.07.009_bib34","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1006\/jmcc.2000.1266","article-title":"Abnormal mitochondrial respiration in failed human myocardium","volume":"32","author":"Sharov","year":"2000","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jchf.2017.07.009_bib35","first-page":"636","article-title":"Skeletal muscle mitochondrial content, oxidative capacity, and Mfn2 expression are reduced in older patients with heart failure and preserved ejection fraction and are related to exercise intolerance","volume":"4","author":"Molina","year":"2016","journal-title":"J\u00a0Am Coll Cardiol HF"},{"key":"10.1016\/j.jchf.2017.07.009_bib36","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.cardfail.2013.10.010","article-title":"Impairment of subendocardial perfusion reserve and oxidative metabolism in nonischemic dilated cardiomyopathy","volume":"19","author":"Bell","year":"2013","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jchf.2017.07.009_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s12350-008-9006-4","article-title":"Impaired myocardial oxidative metabolism in the remote normal region in patients in the chronic phase of myocardial infarction and left ventricular remodeling","volume":"16","author":"Ohte","year":"2009","journal-title":"J\u00a0Nucl Cardiol"},{"key":"10.1016\/j.jchf.2017.07.009_bib38","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.yjmcc.2012.08.025","article-title":"Using metabolomics to assess myocardial metabolism and energetics in heart failure","volume":"55","author":"Turer","year":"2013","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.jchf.2017.07.009_bib39","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.2337\/db09-0580","article-title":"Metabolomics applied to\u00a0diabetes research: moving from information to knowledge","volume":"58","author":"Bain","year":"2009","journal-title":"Diabetes"}],"container-title":["JACC: Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221317791730481X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221317791730481X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,11,6]],"date-time":"2021-11-06T00:31:28Z","timestamp":1636158688000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221317791730481X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":39,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S221317791730481X"],"URL":"https:\/\/doi.org\/10.1016\/j.jchf.2017.07.009","relation":{},"ISSN":["2213-1779"],"issn-type":[{"value":"2213-1779","type":"print"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeted Metabolomic Profiling of Plasma and Survival in Heart Failure Patients","name":"articletitle","label":"Article Title"},{"value":"JACC: Heart Failure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jchf.2017.07.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}